Unlike traditional treatments that target only CSF production, GLP-1 agonists may work through two pathways: Weight loss - a major long-term treatment for IIH Possible CSF pressure effects - GLP-1 receptors on the choroid plexus (where CSF is made) may reduce fluid secretion independent of weight loss The IIH Pressure Trial ( Brain , 2023) found that exenatide lowered intracranial pressure within hours of the first dose
Also assessed was the difference in colorimetric luminosity between melasma and the adjacent unaffected skin
They were left with 4,144 liraglutide, 613 semaglutide, and 654 bupropion-naltrexone users
Amount per
Expert Care : Our professional staff is highly trained to ensure you receive the best possible treatment
3, 2023, Constantine GD, Archer DF, Graham S, Bernick BA, Mirkin S